Enliven Therapeutics
ELVN
#4431
Rank
NZ$4.06 B
Marketcap
NZ$67.99
Share price
2.75%
Change (1 day)
98.09%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$29 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are NZ$29 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$28.6 M1.37%
2024-12-31NZ$28.21 M-31.26%
2023-12-31NZ$41.05 M-83.72%
2022-12-31NZ$0.25 B10.27%
2021-12-31NZ$0.22 B9.06%
2020-12-31NZ$0.20 B